Windlas Biotech Ltd

NSE: WINDLAS · BSE: 543329 · Pharmaceuticals & Biotechnology · 33 announcements

Share price: ₹1,022.00
Market cap: ₹2,145 Cr
Revenue (annual): ₹904.1 Cr
Net profit (annual): ₹66.44 Cr
P/E (TTM): 32.3×Sector 47.3×
Promoter holding: 63.31%+1.41% QoQ
FII holding: 2.04%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Merger & Restructuring 10 Earnings Call 4 Financial Results 3 Results Update 2 Other Announcement 2 Management Change 2 Annual General Meeting 2 Employee Stock Options 1 Dividend 1 Debt & Borrowing 1 Credit Rating 1 Board Meeting Outcome 1 Board Meeting Date 1 Annual Report 1 Adverse Business Impact 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

5 May 2026 18:17 IST NSE

Management Change

Windlas Biotech Management Change

Windlas Biotech Limited appointed Dr. Tarashree Singhal as a Non-Executive Independent Director for a five-year term effective May 5, 2026. Simultaneously, Mr. Srinivasan Venkataraman concluded his tenure as an Independent Director on May 6, 2026. These leadership changes were approved during the board meeting held on May 5, 2026.

Execution: 60 months

Read the filing ↗

5 May 2026 18:09 IST BSE

Management Change

Windlas Biotech Management Change

Windlas Biotech Limited appointed Dr. Tarashree Singhal as an Independent Woman Director for five years effective May 5, 2026. Simultaneously, Mr. Srinivasan Venkataraman ceased to be a director after completing his five-year term. These changes ensure board continuity and compliance with independent director regulations.

Execution: 5 years

Read the filing ↗